
Novocure receives Japanese approval for Optune Pax pancreatic cancer device
Japan approved use with gemcitabine and nab-paclitaxel; Novocure's Oct. 1 release gave no Japanese shipment or coverage date.

Colorado completed its review on Sept. 29; permit issuance requires verified warranties, and DOE mine-plan approval remains pending.

Japan approved use with gemcitabine and nab-paclitaxel; Novocure's Oct. 1 release gave no Japanese shipment or coverage date.

The Erwin, Tennessee, unit will make reactor fuel for the naval propulsion program, with work scheduled for completion in August 2027.
A small post hoc MRI subgroup improved after 72 weeks, while placebo comparisons came from other liver measures in the larger STEP UP dataset.
The uncontrolled Canadian trial enrolled 11 patients; seven were evaluable for pain, and validated data analysis remains underway.

A one-year biomarker analysis could support accelerated approval while the same study runs toward possible full approval.

Enerflex schedules deliveries to an unnamed North American developer from 2027 through 2028 and has authorized US$85M for systems facilities.

Lifted Made closed the Kenosha building sale Sept. 29 and used US$841,110 to repay all its outstanding bank debt.

The FCA approved a prospectus on Sept. 29; MORE starts with a £12 annual dividend per share and has an Oct. 9 retail deadline.
Marimaca's Oct. 1 update names no supplier, contracted volume or energization date for its preliminary five-year power framework.
The Australian explorer is selling 625,000 depositary shares with matching warrants and expects the financing to close Oct. 2.
South Korea's nonbinding financing framework could support up to eight U.S. reactors; Cameco says final agreements and sites remain pending.
A second hole returned 70.41 metres at 1.16 grams per tonne gold, while deeper drilling continues beneath Red Hills.
A Sept. 29 stay in DEA hearing docket 26-96 sets Oct. 13 for a response to a motion seeking to add the GAO report to the record.
Holders have until Oct. 23 to vote on one new share for five to 15 existing shares, nomination rules and incentive-plan entitlements.
The 12-year deal covers two planned data halls backed by a 65 MW utility agreement; prepayment amounts and opening date are undisclosed.
Gold, silver, uranium, lithium, copper and rare earths: the producers, the developers and the projects behind them.
View all
The proposed transfer covers seven reactors and related liabilities, but the Sept. 30 notice gives no price or signing date.
Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.
View all
The monthly 200 mg dose beat placebo at Week 16; patients have already been dosed in two atopic dermatitis Phase 3 studies.
Technology, computing, crypto and cannabis, and the listed companies moving in them.
View all
Commerce's Bureau of Industry and Security authorised sales under specified terms; the company did not name an export buyer or shipment date.
Jabil expects US$17.55 core EPS and a 6.1 per cent core operating margin in fiscal 2027 after quarterly revenue rose year on year.
Uranium, lithium, oil and gas, hydrogen and the grid: the fuels and the companies behind them.
View all
The first hole's 1.1-metre section graded 1.10 per cent, while assays from 18 more drilled holes remain outstanding.

Amentum says Sellafield's PACE framework would run for nine years, with an option to extend it by six years.

The Sept. 30 agreement covers tape for ARC fusion plants, but neither the purchase price nor the first delivery date was disclosed.
Licensed producers, retail, policy, and the psychedelics companies moving through the clinic.
View all
Battle Green can require a share-funded note purchase, while Vireo can trigger one at a lower share price; the maturity route uses a future trading average.

IMC Holdings retains liabilities under a C$9.4M cap subject to mutual adjustment; direct subsidiary debts are excluded from that cap.

The cannabis banking platform expects SHFS to keep its Nasdaq ticker and round fractional holdings up when split-adjusted trading begins Sept. 30.

The perpetual, royalty-free agreement covers two brands, while a Texas launch still requires final state licensure and regulatory approval.